Moores Cancer Center, University of California, San Diego, La Jolla, CA.
J Oncol Pract. 2017 Sep;13(9):e760-e769. doi: 10.1200/JOP.2017.020883. Epub 2017 Aug 22.
Palliative care's role in oncology has expanded, but its effect on aggressiveness of care at the end of life has not been characterized at the population level.
This matched retrospective cohort study examined the effect of an encounter with palliative care on health-care use at the end of life among 6,580 Medicare beneficiaries with advanced prostate, breast, lung, or colorectal cancer. We compared health-care use before and after palliative care consultation to a matched nonpalliative care cohort.
The palliative care cohort had higher rates of health-care use in the 30 days before palliative care consultation compared with the nonpalliative cohort, with higher rates of hospitalization (risk ratio [RR], 3.33; 95% CI, 2.87 to 3.85), invasive procedures (RR, 1.75; 95% CI, 1.62 to 1.88), and chemotherapy administration (RR, 1.61; 95% CI, 1.45 to 1.78). The opposite pattern emerged in the interval from palliative care consultation through death, where the palliative care cohort had lower rates of hospitalization (RR, 0.53; 95% CI, 0.44-0.65), invasive procedures (RR, 0.52; 95% CI, 0.45 to 0.59), and chemotherapy administration (RR, 0.46; 95% CI, 0.39 to 0.53). Patients with earlier palliative care consultation in their disease course had larger absolute reductions in health-care use compared with those with palliative care consultation closer to the end of life.
This population-based study found that palliative care substantially decreased health-care use among Medicare beneficiaries with advanced cancer. Given the increasing number of elderly patients with advanced cancer, this study emphasizes the importance of early integration of palliative care alongside standard oncologic care.
姑息治疗在肿瘤学中的作用已经扩大,但它对人群水平上生命末期治疗积极性的影响尚未得到描述。
本项匹配的回顾性队列研究调查了在 6580 名患有晚期前列腺癌、乳腺癌、肺癌或结直肠癌的医疗保险受益人群中,姑息治疗会诊对生命末期医疗保健使用的影响。我们将姑息治疗咨询前后的医疗保健使用情况与匹配的非姑息治疗队列进行了比较。
姑息治疗组在姑息治疗咨询前 30 天的医疗保健使用量高于非姑息治疗组,住院率更高(风险比 [RR],3.33;95%置信区间 [CI],2.87 至 3.85)、侵入性操作(RR,1.75;95%CI,1.62 至 1.88)和化疗管理(RR,1.61;95%CI,1.45 至 1.78)。相反的模式出现在姑息治疗咨询到死亡的间隔期间,姑息治疗组的住院率(RR,0.53;95%CI,0.44 至 0.65)、侵入性操作(RR,0.52;95%CI,0.45 至 0.59)和化疗管理(RR,0.46;95%CI,0.39 至 0.53)的降低率更低。在疾病过程中较早接受姑息治疗咨询的患者与接近生命末期接受姑息治疗咨询的患者相比,医疗保健使用量的绝对减少幅度更大。
本基于人群的研究发现,姑息治疗显著降低了医疗保险受益人群中晚期癌症患者的医疗保健使用量。鉴于患有晚期癌症的老年患者数量不断增加,本研究强调了在标准肿瘤学治疗的基础上尽早整合姑息治疗的重要性。